SOLV
Solventum Corporation NYSE Listed Apr 1, 2024$71.61
Mkt Cap $12.4B
52w Low $62.38
35.7% of range
52w High $88.20
50d MA $67.81
200d MA $73.80
P/E (TTM)
7.5x
EV/EBITDA
7.0x
P/B
2.3x
Debt/Equity
1.0x
ROE
30.8%
P/FCF
-1379.6x
RSI (14)
—
ATR (14)
—
Beta
0.77
50d MA
$67.81
200d MA
$73.80
Avg Volume
1.3M
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.
3M Center · Maplewood, MN 55144 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | AMC | 1.35 | 1.48 | +9.6% | 69.04 | -1.5% | +2.8% | +0.9% | — | — | — | — |
| Feb 26, 2026 | AMC | 1.50 | 1.57 | +4.7% | 76.94 | -5.1% | -3.6% | -1.6% | -3.0% | -0.6% | +0.5% | — |
| Nov 6, 2025 | AMC | 1.43 | 1.50 | +4.9% | 66.28 | +3.5% | +7.9% | +0.4% | +2.9% | -0.1% | +1.9% | — |
| Aug 7, 2025 | AMC | 1.45 | 1.69 | +16.6% | 71.95 | +3.4% | +2.0% | -2.1% | +0.3% | +3.2% | -1.6% | — |
| May 8, 2025 | AMC | 1.21 | 1.34 | +10.7% | 66.63 | +2.0% | +5.4% | +6.5% | -1.7% | -3.2% | +2.5% | — |
| Feb 27, 2025 | AMC | 1.31 | 1.41 | +7.6% | 83.44 | -3.0% | -4.4% | +0.5% | -1.5% | -1.5% | -2.7% | — |
| Nov 7, 2024 | AMC | 1.39 | 1.64 | +18.0% | 75.07 | +2.0% | -3.5% | -1.2% | -1.2% | -0.9% | -3.1% | — |
| Aug 8, 2024 | AMC | 1.51 | 1.56 | +3.3% | 58.66 | +2.3% | +3.3% | -4.8% | +0.9% | -0.8% | +1.8% | — |
| May 9, 2024 | AMC | 1.75 | 2.08 | +18.9% | 64.83 | -1.6% | -1.7% | -0.9% | +3.1% | -4.1% | -1.4% | — |
| Dec 31, 2023 | AMC | — | 0.42 | — | — | — | — | — | — | — | — | — |
| Sep 30, 2023 | AMC | — | 1.65 | — | — | — | — | — | — | — | — | — |
| Jun 30, 2023 | AMC | — | 1.86 | — | — | — | — | — | — | — | — | — |
| Mar 31, 2023 | AMC | — | 1.70 | — | — | — | — | — | — | — | — | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 27 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $68.52 | $68.32 | -0.3% | +1.8% | -3.3% | -1.5% | +1.3% | -1.1% |
| Apr 17 | Piper Sandler | Maintains | Overweight → Overweight | — | $68.88 | $70.00 | +1.6% | +2.3% | -0.6% | -1.5% | +0.2% | -0.2% |
| Feb 27 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $76.94 | $73.00 | -5.1% | -3.6% | -1.6% | -3.0% | -0.6% | +0.5% |
| Feb 27 | BTIG | Maintains | Buy → Buy | — | $76.94 | $73.00 | -5.1% | -3.6% | -1.6% | -3.0% | -0.6% | +0.5% |
| Feb 27 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $76.94 | $73.00 | -5.1% | -3.6% | -1.6% | -3.0% | -0.6% | +0.5% |
| Jan 26 | KeyBanc Capital Markets | Upgrade | Sector Weight → Overweight | — | $78.91 | $80.13 | +1.5% | +0.1% | -1.8% | -1.3% | -0.1% | +0.6% |
| Jan 20 | Mizuho | Upgrade | Neutral → Outperform | — | $79.48 | $79.56 | +0.1% | -0.7% | +1.8% | -0.1% | -1.7% | +0.1% |
| Jan 7 | Stifel | Maintains | Buy → Buy | — | $83.16 | $83.75 | +0.7% | +1.3% | +1.8% | +0.4% | -0.5% | -6.6% |
| Dec 2 | BTIG | Upgrade | Neutral → Buy | — | $85.56 | $87.30 | +2.0% | +0.0% | -0.4% | +0.0% | +0.2% | -3.3% |
| Nov 10 | UBS | Maintains | Neutral → Neutral | — | $71.52 | $71.25 | -0.4% | +0.4% | +2.9% | -0.1% | +1.9% | +0.6% |
| Nov 7 | Piper Sandler | Maintains | Overweight → Overweight | — | $66.28 | $68.62 | +3.5% | +7.9% | +0.4% | +2.9% | -0.1% | +1.9% |
| Sep 15 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $73.39 | $73.33 | -0.1% | -0.2% | +1.3% | -0.1% | +0.4% | -0.9% |
| Aug 8 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $71.95 | $74.38 | +3.4% | +2.0% | -2.1% | +0.3% | +3.2% | -1.6% |
| Aug 8 | Piper Sandler | Maintains | Overweight → Overweight | — | $71.95 | $74.38 | +3.4% | +2.0% | -2.1% | +0.3% | +3.2% | -1.6% |
| Jul 15 | Morgan Stanley | Upgrade | Equal Weight → Overweight | — | $74.07 | $76.22 | +2.9% | -0.5% | -0.9% | +1.1% | -0.8% | -1.3% |
| Jul 1 | Argus | Upgrade | Hold → Buy | — | $75.84 | $76.73 | +1.2% | +2.7% | +0.5% | +0.3% | -2.9% | -1.5% |
| May 19 | Piper Sandler | Upgrade | Neutral → Overweight | — | $74.11 | $74.75 | +0.9% | +2.2% | -1.4% | -2.6% | -0.1% | -2.5% |
| May 9 | Piper Sandler | Maintains | Neutral → Neutral | — | $66.63 | $67.96 | +2.0% | +5.4% | +6.5% | -1.7% | -3.2% | +2.5% |
| Apr 30 | Piper Sandler | Maintains | Neutral → Neutral | — | $66.25 | $65.68 | -0.9% | -0.2% | -0.8% | +3.0% | -1.1% | -2.1% |
| Mar 5 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $78.99 | $78.80 | -0.2% | -1.5% | -2.7% | +2.9% | -0.4% | -2.3% |
| Mar 3 | Mizuho | Maintains | Neutral → Neutral | — | $79.75 | $79.76 | +0.0% | +0.5% | -1.5% | -1.5% | -2.7% | +2.9% |
| Mar 3 | Goldman Sachs | Maintains | Sell → Sell | — | $79.75 | $79.76 | +0.0% | +0.5% | -1.5% | -1.5% | -2.7% | +2.9% |
| Feb 28 | Piper Sandler | Maintains | Neutral → Neutral | — | $83.44 | $80.95 | -3.0% | -4.4% | +0.5% | -1.5% | -1.5% | -2.7% |
| Feb 28 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $83.44 | $80.95 | -3.0% | -4.4% | +0.5% | -1.5% | -1.5% | -2.7% |
| Feb 26 | BofA Securities | Maintains | Neutral → Neutral | — | $83.56 | $83.50 | -0.1% | +0.6% | -0.7% | -4.4% | +0.5% | -1.5% |
| Nov 11 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $72.43 | $72.22 | -0.3% | -1.2% | -1.2% | -0.9% | -3.1% | -0.6% |
| Nov 8 | Piper Sandler | Maintains | Neutral → Neutral | — | $75.07 | $76.60 | +2.0% | -3.5% | -1.2% | -1.2% | -0.9% | -3.1% |
| Aug 12 | Goldman Sachs | Maintains | Sell → Sell | — | $60.59 | $60.59 | +0.0% | -4.8% | +0.9% | -0.8% | +1.8% | +1.0% |
| Aug 9 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $58.66 | $60.00 | +2.3% | +3.3% | -4.8% | +0.9% | -0.8% | +1.8% |
| Jul 15 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $49.00 | $48.78 | -0.4% | -1.6% | +3.8% | +5.9% | +3.7% | -0.7% |
| Jul 10 | Goldman Sachs | Maintains | Sell → Sell | — | $48.02 | $48.10 | +0.2% | +0.3% | +2.4% | -0.7% | -1.6% | +3.8% |
| Jun 25 | BofA Securities | Maintains | Neutral → Neutral | — | $51.30 | $51.24 | -0.1% | -0.1% | -1.0% | +1.1% | +3.0% | -2.7% |
No insider trades available.
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
SOLV's departure of a key executive signals potential leadership instability and operational uncertainty, which could pressure the stock until management clarity emerges.
Mar 24
8-K
Solventum Corporation -- 8-K Filing
Solventum exceeded 2025 full-year sales and EPS expectations with strong fourth-quarter performance, delivering $0.36 GAAP and $1.57 adjusted diluted EPS, signaling operational momentum and execution on transformation initiatives.
Feb 26
Data updated apr 27, 2026 2:24am
· Source: massive.com